Skip to main content

Varicella virus vaccine Side Effects

Medically reviewed by Drugs.com. Last updated on Mar 22, 2023.

Applies to varicella virus vaccine: powder for suspension.

Serious side effects

Along with its needed effects, varicella virus vaccine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking varicella virus vaccine:

More common

Less common

Rare

Incidence not known

Other side effects

Some side effects of varicella virus vaccine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Incidence not known

For Healthcare Professionals

Applies to varicella virus vaccine: injectable powder for injection, subcutaneous powder for injection.

General

The most common adverse events were injection site reactions and fever.[Ref]

Other

Very common (10% or more): Fever (27%), otitis media (12%)

Uncommon (0.1% to 1%): Otitis, viral infection, asthenia, hematoma, malaise

Rare (less than 0.1%): Ear pain, infection, candidiasis, non-venomous bite/sting, heaviness

Frequency not reported: Insect bites[Ref]

Local

Very common (10% or more): Injection site complaints (pain/soreness, swelling and/or erythema, rash, pruritus, hematoma, induration, stiffness) (32.5%)

Common (1% to 10%): Varicella-like rash (injection site)

Uncommon (0.1% to 1%): Injection site ecchymosis, induration

Rare (less than 0.1%): Extravasation, injection site eczema, lump, warmth, stiffness, pain/tenderness/soreness, warm sensation, warm to touch, venipuncture site hemorrhage[Ref]

Respiratory

Very common (10% or more): Upper respiratory infection (26.9%), cough (11%)

Common (1% to 10%): Rhinorrhea

Uncommon (0.1% to 1%): Nasal congestion, respiratory congestion, influenza, pharyngitis

Rare (less than 0.1%): Pneumonitis, sinusitis, sneezing, pulmonary congestion, epistaxis, rhinitis, wheezing, bronchitis, respiratory infection, pneumonia, flu-like illness

Frequency not reported: Upper respiratory illness, lower respiratory illness[Ref]

Dermatologic

Common (1% to 10%): Varicella-like rash (generalized), rash, measles/rubella-like rash

Uncommon (0.1% to 1%): Varicella, viral exanthema, contact dermatitis, diaper rash, erythema, miliaria rubra, pruritus, urticaria

Rare (less than 0.1%): Flushing, vesicle, atopic dermatitis, eczema, acne, herpes simplex, contusion, dermatitis, drug eruption, impetigo, skin infection, measles, sunburn, lump, warmth, discoloration, inflammation, roughness/dryness, hive-like rash, hyperpigmentation

Postmarketing reports: Varicella (vaccine strain), Stevens-Johnson syndrome, erythema multiforme, Henoch-Schonlein purpura, secondary bacterial infections of skin and soft tissue including cellulitis, herpes zoster[Ref]

Psychiatric

Common (1% to 10%): Irritability

Uncommon (0.1% to 1%): Crying, insomnia, sleep disorder

Rare (less than 0.1%): Apathy, nervousness, agitation, dream abnormality, emotional changes

Frequency not reported: Disturbed sleep[Ref]

Gastrointestinal

Uncommon (0.1% to 1%): Gastroenteritis, diarrhea, vomiting

Rare (less than 0.1%): Abdominal pain, nausea, flatulence, hematochezia, mouth ulcer, lip abnormality

Frequency not reported: Constipation, cold/canker sore[Ref]

Nervous system

Uncommon (0.1% to 1%): Headache, somnolence, fatigue

Rare (less than 0.1%): Febrile seizures, hypersomnia, gait abnormality, tremor

Postmarketing reports: Encephalitis, cerebrovascular accident, transverse myelitis, Guillain-Barré syndrome, Bell's palsy, ataxia, non-febrile seizures, aseptic meningitis, dizziness, paresthesia[Ref]

Hematologic

Rare (less than 0.1%): Lymphadenopathy, lymphadenitis, thrombocytopenia

Postmarketing reports: Aplastic anemia, idiopathic thrombocytopenic purpura[Ref]

Hypersensitivity

Frequency not reported: Allergic reactions (including allergic rash, hives)

Postmarketing reports: Anaphylaxis (including anaphylactic shock) and related phenomena such as angioneurotic edema, facial edema, and peripheral edema; anaphylaxis in individuals with or without an allergic history[Ref]

Ocular

Uncommon (0.1% to 1%): Conjunctivitis

Rare (less than 0.1%): Acute conjunctivitis, tearing, edema of the eyelid, irritation

Frequency not reported: Eye complaints

Postmarketing reports: Necrotizing retinitis (in immunocompromised individuals)[Ref]

Metabolic

Uncommon (0.1% to 1%): Anorexia[Ref]

Musculoskeletal

Rare (less than 0.1%): Musculoskeletal pain, myalgia, stiffness, pain of the hip, leg, or neck

Frequency not reported: Chills, stiff neck, arthralgia[Ref]

Frequently asked questions

References

1. Product Information. Varivax (varicella virus vaccine). Merck & Co., Inc. 2022.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

3. Cerner Multum, Inc. Australian Product Information.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.